|

Respiratory Training in the Treatment of Transdiagnostic Pathological Anxiety

RECRUITINGN/ASponsored by University of Texas at Austin
Actively Recruiting
PhaseN/A
SponsorUniversity of Texas at Austin
Started2022-08-22
Est. completion2027-05
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site

Summary

Purpose of the Research: The primary aim of the proposed study is to conduct a randomized parallel-group 2-arm clinical trial investigating capnometry-guided respiratory intervention (CGRI) for pathological anxiety. CGRI aims to raise end-tidal CO2 levels thereby lowering hyperventilation-induced respiratory alkalosis and its associated fear-eliciting somatic reactions. Psycho-education about anxiety and its effects (PsyEd) will serve as a credible control comparator.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

1. Clinically elevated anxiety as indicated by an eight or higher on the Overall Anxiety Severity and Impairment Scale (OASIS).
2. Meets DSM-5 criteria for one or more of the following anxiety or trauma-related disorders as their "primary" mental disorder:

   * Generalized Anxiety Disorder
   * Panic Disorder
   * Health Anxiety
   * Agoraphobia
   * Social Anxiety Disorder
   * Posttraumatic Stress Disorder
   * Acute Stress Disorder
   * Adjustment Disorder with primary anxious mood
   * Anxiety disorder not otherwise specified
3. No current use of psychotropic medications or stable on current medications for at least 6 weeks
4. Age 18+.
5. Able to arrange transportation to our laboratory for study appointments.
6. Fluent in English.

Exclusion Criteria:

1. No history of medical conditions that would contraindicate participation in fear-provocation or respiratory challenges, including:

   * Cardiovascular or respiratory disorders
   * High blood pressure
   * Epilepsy
   * Strokes
   * Seizures
   * History of fainting
   * Pregnant or lactating
2. Not currently receiving other psychological treatment for anxiety.
3. No history of a suicide attempt within the past 6 months.
4. No history of psychosis within the past 6 months.
5. No history of moderate to severe alcohol or substance use disorder (with the exception of nicotine) within the past 3 months.
6. Does not endorse COVID-19 symptoms during the screening phase.

Conditions11

Acute Stress DisorderAdjustment Disorder With Anxious MoodAgoraphobiaAnxietyAnxiety DisordersGeneralized Anxiety DisorderIllness Anxiety DisorderPanic DisorderPosttraumatic Stress DisorderSocial Anxiety Disorder

Locations1 site

University of Texas at Austin
Austin, Texas, 78712
Michael J Telch, PhD512-814-5480telch@austin.utexas.edu

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.